Mirouze J, Marchal G, Orsetti A, Jaffiol C, Monnier L, Baldet P, Piperno M, Hedon B
Acta Diabetol Lat. 1978 May-Aug;15(3-4):205-11. doi: 10.1007/BF02581066.
In a 46-year old Caucasian woman, the authors report a B-cell adenoma with plasma immunoreactive insulin (IRI) ranging from 10 to 32 microunits/ml, despite severe spontaneous hypoglycemia. In a peroperative sample withdrawn from the portal vein, normal IRI (40 micromicron/ml) in the presence of high insulin-like activity (290 microunits/ml) was observed by using a biological assay performed on rat epididymal fat tissue. Furthermore, this material did not cross-react with insulin antibodies and was undetectable in systemic venous samples. Although further identification by chromatographic extraction was not performed, the substance secreted by the tumor is probably identical to the non-suppressible insulin-like activity (NSILA) isolated by Froesch and responsible for hypoglycemia in a few cases of extrapancreatic tumors. The absence of this material in systemic samples indicates an immediate removal by a single passage through the liver.
作者报告了一名46岁的白种女性,患有B细胞腺瘤,尽管存在严重的自发性低血糖,但血浆免疫反应性胰岛素(IRI)水平在10至32微单位/毫升之间。在从门静脉抽取的术中样本中,通过对大鼠附睾脂肪组织进行生物测定,观察到在高胰岛素样活性(290微单位/毫升)存在的情况下,IRI正常(40微微单位/毫升)。此外,该物质与胰岛素抗体无交叉反应,在全身静脉样本中无法检测到。尽管未通过色谱提取进行进一步鉴定,但肿瘤分泌的物质可能与Froesch分离出的不可抑制胰岛素样活性(NSILA)相同,在一些胰腺外肿瘤病例中,NSILA会导致低血糖。全身样本中不存在这种物质,表明其在单次通过肝脏时即被立即清除。